מולטיביק ללא אשלגן

Country: Israel

Language: Hebrew

Source: Ministry of Health

Buy It Now

Active ingredient:

CALCIUM CHLORIDE DIHYDRATE; GLUCOSE AS MONOHYDRATE; MAGNESIUM CHLORIDE HEXAHYDRATE; SODIUM CARBONATE HYDROGEN; SODIUM CHLORIDE

Available from:

FRESENIUS MEDICAL CARE ISRAEL P.B. LTD

ATC code:

B05XA30

Pharmaceutical form:

תמיסה להמודיאליזה\המופילטרציה

Composition:

SODIUM CHLORIDE 6.136 G/L; CALCIUM CHLORIDE DIHYDRATE 0.2205 G/L; SODIUM CARBONATE HYDROGEN 2.940 G/L; GLUCOSE AS MONOHYDRATE 1 G/L; MAGNESIUM CHLORIDE HEXAHYDRATE 0.1017 G/L

Administration route:

תוך-ורידי

Prescription type:

מרשם נדרש

Manufactured by:

FRESENIUS MEDICAL CARE DEUTSCHLAND GMBH, GERMANY

Therapeutic group:

COMBINATIONS OF ELECTROLYTES

Therapeutic area:

COMBINATIONS OF ELECTROLYTES

Therapeutic indications:

For use in patients with acute renal failure, requiring continuous haemofiltration.

Authorization date:

2022-01-31

Documents in other languages

Public Assessment Report Public Assessment Report English 17-08-2016